2162.HK
Price:
$49
Market Cap:
$12.34B
Keymed Biosciences Inc., a biotechnology company, engages in the research and development of biological therapies for the treatment of autoimmunity and oncology diseases. Its lead product candidate is CM310 for the treatment of moderate to severe atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), and chronic obstructive pulmonary disease (COPD). The company is also developing CM326, a monoclonal antibody targeting thymic stromal lymphopoietin to treat moderate-to severe AD, CRSwNP, asthma, and COPD. In addition, it develops CMG901 for the treatment of solid tumors, and gastric and gastroesophageal cancers; and CM313, a humanized monoclonal antibody to treat...[Read more]
Industry
Biotechnology
IPO Date
2021-07-08
Stock Exchange
HKSE
Ticker
2162.HK
According to Keymed Biosciences Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.30. This represents a change of -57.96% compared to the average of 7.85 of the last 4 quarters.
The mean historical Current Ratio of Keymed Biosciences Inc. over the last ten years is 10.89. The current 3.30 Current Ratio has changed 2.93% with respect to the historical average. Over the past ten years (40 quarters), 2162.HK's Current Ratio was at its highest in in the December 2021 quarter at 31.96. The Current Ratio was at its lowest in in the June 2019 quarter at 0.
Average
10.89
Median
7.98
Minimum
3.30
Maximum
31.96
Discovering the peaks and valleys of Keymed Biosciences Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 573.24%
Maximum Annual Current Ratio = 31.96
Minimum Annual Increase = -72.72%
Minimum Annual Current Ratio = 3.30
Year | Current Ratio | Change |
---|---|---|
2024 | 3.30 | -64.75% |
2023 | 9.36 | 7.33% |
2022 | 8.72 | -72.72% |
2021 | 31.96 | 573.24% |
2020 | 4.75 | -34.44% |
The current Current Ratio of Keymed Biosciences Inc. (2162.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.12
5-year avg
11.62
10-year avg
10.89
Keymed Biosciences Inc.’s Current Ratio is less than CARsgen Therapeutics Holdings Limited (6.02), less than Brii Biosciences Limited (31.18), less than Zylox-Tonbridge Medical Technology Co., Ltd. (4.58), greater than Simcere Pharmaceutical Group Limited (2.00), less than Medlive Technology Co., Ltd. (21.03),
Company | Current Ratio | Market cap |
---|---|---|
6.02 | $13.50B | |
31.18 | $1.26B | |
4.58 | $6.01B | |
2.00 | $28.06B | |
21.03 | $11.05B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Keymed Biosciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Keymed Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Keymed Biosciences Inc.'s Current Ratio?
How is the Current Ratio calculated for Keymed Biosciences Inc. (2162.HK)?
What is the highest Current Ratio for Keymed Biosciences Inc. (2162.HK)?
What is the 3-year average Current Ratio for Keymed Biosciences Inc. (2162.HK)?
What is the 5-year average Current Ratio for Keymed Biosciences Inc. (2162.HK)?
How does the current Current Ratio for Keymed Biosciences Inc. (2162.HK) compare to its historical average?